65 results
424B3
SRZN
Surrozen Inc
8 Nov 23
Prospectus supplement
4:27pm
physician education programs;
the availability of coverage and adequate government and third-party payor reimbursement;
the pricing of our products … . These include the lack of widespread availability of, and limited reimbursement for, new therapies in many underdeveloped markets.
We face competition from
424B3
bwsxa jffim
9 Aug 23
Prospectus supplement
4:39pm
8-K
EX-10.1
ksb0kl4
19 Jul 23
Departure of Directors or Certain Officers
4:15pm
424B3
m4dswqi3ii8rpownho
10 May 23
Prospectus supplement
4:47pm
424B3
bv443qaab erh
7 Apr 23
Prospectus supplement
5:20pm
POS AM
wmswyv
31 Mar 23
Prospectus update (post-effective amendment)
9:09am
S-3
EX-1.2
j8hjsf1 ir0szodo56o
9 Dec 22
Shelf registration
5:31pm
S-3
EX-4.4
etlp4ilj
9 Dec 22
Shelf registration
5:31pm
424B3
vbjvnrfauvbbq0l
15 Nov 22
Prospectus supplement
6:30am
424B3
82u1px1qndbh788
15 Nov 22
Prospectus supplement
6:30am